Key facts
- This page summarizes Timothy Eugene Sullivan's Form 4 filing for Apellis Pharmaceuticals, Inc. (APLS).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 09 Jun 2021, 16:06.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
This option was granted on October 18, 2017 and will vest as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.